Rick Matthews/LikedIn
Mar 9, 2026, 13:49
Rick Matthews: Looking Beyond Clot Clearance in Long-Term Management After DVT
Rick Matthews, Senior Vascular Consultant at Argon Medical Devices, Inc., shared on LinkedIn:
”We talk a lot about ‘clearing clot today’ with modern mechanical thrombectomy/PMT options, but the long game is what patients live with: recurrent ipsilateral DVT risk, valve injury, chronic outflow obstruction, and structured follow-up.
Are you routinely documenting Villalta at 3–6 months after DVT (and repeating at ~12 months), or is it still inconsistent across services?
PTS symptoms often reflect the net effect of obstruction plus reflux plus microvascular injury—so the pathway has to be stepwise.
My simple escalation triggers (baked into any VTE program):
- Villalta ≥10 / meaningful functional limitation
- Venous claudication
- Skin changes or ulcer
- New/worsening swelling – rule out recurrent DVT first”
Stay updated with Hemostasis Today.
-
Nov 2, 2026, 12:17Mokhtar Tazik: Plasma Self-Sufficiency and Sustainable Access
-
Nov 2, 2026, 12:09Alejandro González Veliz: Does More Calcium Mean More Stability
-
Nov 2, 2026, 12:05Zeev Dvashi: Advancing Synthetic Blood Technologies for Battlefield Medicine
-
Nov 2, 2026, 11:56Rob Maloney: Strengthening Patient Advocacy in Bleeding Disorders
-
Nov 2, 2026, 11:46William McKeown: Advancing Gene and Cell Therapies for Inherited Bleeding Disorders
-
Nov 2, 2026, 11:41Anawat Ratchatorn: Identifying Stroke Mimics in the Emergency Department
-
Nov 2, 2026, 11:29Shruti Gadgil: AI-Powered Smartphone Screening for Anemia Severity in Rural India
-
Nov 2, 2026, 10:41Paulus Kirchhof: Smoking or Vaping – Nicotine Still Affects Vascular Health
-
Nov 2, 2026, 10:30Asesa Omullo: Connecting Sickle Cell Advocates at GANSID 2026